Interní Med. 2002; 4(12): 582-586

Problematika jícnových varixů u nemocných s jaterní cirhózou

doc. MUDr. Jan Lata CSc
III. interní klinika gastroenterologická, FN Brno-Bohunice

Keywords: liver cirrhosis, oesophageal varices, bleeding, therapy.

Published: December 31, 2002  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Lata J. Problematika jícnových varixů u nemocných s jaterní cirhózou. Interní Med. 2002;4(12):582-586.

V článku je diskutována problematika vzniku jícnových varixů při portální hypertenzi, jejich možné ruptury s následným krvácením a možnosti léčby. Je podán přehled léčby akutního krvácení i možnosti primární a sekundární prevence.

Oesophageal varices in patients with liver cirrhosis

This article deals with the development of oesophageal varices in portal hypertension, their potential rupture and consequential bleeding, and the possible treatment modalities. A survey of the management of an acute bleed is given, and the possibilities for primary and secondary prevention are discussed.

Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Conn HO, Lindenmuth WW, May CJ, Rambsy GR. Prophylactic portacaval anastomosis: a tale of two studies. Medicine 1972; 51: 27-40. Go to original source... Go to PubMed...
    2. Číselník VZP-HVLP, verze 320, 1999.
    3. D´Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995; 22: 332-354. Go to original source... Go to PubMed...
    4. Emenike E, Srivastava S, Amoateng-Adjepong Y, Al-Kharrat T, Zarich S, Manthous AC. Myocardial infarction complicating gastrointestinal hemorrhage. Mayo Clin Proc 1999; 74: 235-241. Go to original source... Go to PubMed...
    5. García-Villarreal L, Martínez-Lagaares F, Sierra A, Guevara C, Marrero JM, Jiménez E, Monescillo A, Hernández-Cabrero T, et al. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage. Hepatology 1999; 29: 27-32. Go to original source... Go to PubMed...
    6. Grace ND, Groszmann RJ, Garcia-Tsao G, Burroughs AK, Pagliaro L, Makuch RW, Bosch J et al. Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology 1998; 28(3): 868-878. Go to original source... Go to PubMed...
    7. Helton WC, Belshaw A, Althaus S, Park S, Coldwell D, Johansen K. Critical appraisal of the angiographic portacaval shunt (TIPS). Am J Surg 1993; 165: 566-571. Go to original source... Go to PubMed...
    8. Mann NS, Hillis A, Mann SK, Buerk CA, Prasad VM. In cirrhotic patients variceal bleeding is more frequent in the evening and correlates with severity of liver disease. Hepato-gastroenterology 1999; 46: 391-394. Go to PubMed...
    9. Laine L, Cook D. Endoscopic ligation compared with sclerotherapy for treatment of esofageal variceal bleeding: a metaanalysis. Ann Intern Med 1995; 123: 180-197. Go to original source... Go to PubMed...
    10. Lavacher S, Letoumelin P, Pateron D, Blaise M, Lapandry C, Pourriat JL. Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients. Lancet 1995; 346: 865-868. Go to original source... Go to PubMed...
    11. Lay CS, Tsai YT, Teg CY, et al. Endoscopic variceal ligation in prophylaxis of first variceal bleeding in cirrhotic patients with high-risk esophageal varices. Hepatology 1997; 25: 1346-1350. Go to original source... Go to PubMed...
    12. Lebrec D. Pharmacotherapeutic agents in the treatment of portal hypertension. J Gastroenterol Hepatol 1997; 12: 159-166. Go to original source... Go to PubMed...
    13. Lebrec D. Pharmacological treatment of portal hypertension: present and future. J Hepatol 1998; 28: 896-907. Go to original source... Go to PubMed...
    14. Orloff J, Orloff MS, Rambotti M, Girard B. Three decades of experience with emergency portacaval shunt for acutely bleeding esophageal varices in 400 unselected patients with cirrhosis of the liver. J Am Coll Surg 1995; 179: 257-272.
    15. Stanley AJ, Robinson I, Forrest EH, Jones AL, Hayes PC. Haemodynamic parameters predicting variceal haemorrhage and survival in alcoholic cirrhosis. QJM 1998; 91(1): 19-25. Go to original source... Go to PubMed...
    16. The North Italian Endoskopic Club for the Study of Treatment of Esophageal Varices: Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. N Engl J Med 1988; 13: 983-989. Go to original source... Go to PubMed...
    17. Vlavianos P, Gimson AES, Westaby D, Williams R. Baloon tamponade in variceal bleeding: use and misuse. BMJ 1989; 298: 1158-1165. Go to original source... Go to PubMed...
    18. Zacks S, Sandler RS, Biddle AK, Mauro MA, Brown RS. Decision-analysis of transjugular intraheptic portosystemic shunt versus distal splenorenal shunt for portal hypertension. Hepatology 1999; 29,3: 1399-1405. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.